WallStreetZenWallStreetZen

NASDAQ: APYX
Apyx Medical Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Apyx Medical revenue was $48.10M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $14.2M, up 23.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, APYX annual revenue was $48.1M, with -8.1% growth year-over-year.

APYX past revenue growth

How has APYX's revenue growth performed historically?

Company
-8.11%
Industry
10.74%
Market
20.27%
APYX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
APYX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
APYX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

APYX revenue history

Current Revenue
$48.1M
Current Earnings
-$23.5M
Current Profit Margin
-48.8%

Be the first to know when APYX announces revenue.

APYX Revenue History By Year

APYX Yearly RevenueAPYX RevenueAPYX ChangeAPYX Revenue Growth
2024-12-31$48.10M-$4.25M-8.11%
2023-12-31$52.35M$7.84M+17.61%
2022-12-31$44.51M-$4.01M-8.26%
2021-12-31$48.52M$20.81M+75.08%
2020-12-31$27.71M-$524.00k-1.86%
2019-12-31$28.24M$11.63M+70.04%
2018-12-31$16.61M$6.37M+62.25%
2017-12-31$10.23M$1.42M+16.04%
2016-12-31$8.82M-$20.70M-70.13%
2015-12-31$29.52M$1.84M+6.64%
2014-12-31$27.68M$4.02M+16.99%
2013-12-31$23.66M-$4.01M-14.50%
2012-12-31$27.67M$2.26M+8.89%
2011-12-31$25.41M$1.18M+4.87%
2010-12-31$24.23M-$2.72M-10.10%
2009-12-31$26.95M-$1.14M-4.07%
2008-12-31$28.10M-$682.16k-2.37%
2007-12-31$28.78M$2.10M+7.88%
2006-12-31$26.68M$6.47M+31.99%
2005-12-31$20.21M-$283.96k-1.39%
2004-12-31$20.50M$4.38M+27.16%
2003-12-31$16.12M$3.67M+29.50%
2002-12-31$12.45M$913.76k+7.92%
2001-12-31$11.53M$1.60M+16.07%
2000-12-31$9.94M$243.17k+2.51%
1999-12-31$9.69M$1.25M+14.82%
1998-12-31$8.44M$1.07M+14.52%
1997-12-31$7.37M-$114.62k-1.53%
1996-12-31$7.49MN/AN/A

1 of 2

Apyx Medical Revenue FAQ

What was APYX's revenue last quarter?

On Invalid Date, Apyx Medical (NASDAQ: APYX) reported Q4 2024 revenue of $14.22 million up 3% year over year. In the same quarter last year, Apyx Medical's revenue was $14.66 million.

What was Apyx Medical's revenue in 2024?

Apyx Medical's annual revenue for the twelve months ending Dec 31, 2024 was $48.10 million, a 8.11% decrease year over year.

How much does Apyx Medical make in a day?

Based on Apyx Medical annual revenue for the past five years, APYX makes an average of $121,199.45 per day.

What was Apyx Medical's annual revenue growth in the past year?

As of Q2 2025, Apyx Medical's revenue has grown -8.11% year over year. This is 18.85 percentage points lower than the US Medical Devices industry revenue growth rate of 10.74%. Apyx Medical's revenue in the past year totaled $48.10 million.

How much does Apyx Medical make in a year?

Apyx Medical's revenue by year for the past five years is:
  • Apyx Medical's revenue for the twelve months ending Dec 31, 2024 was $48.10 million, a 8.11% decrease year over year.
  • Apyx Medical's annual revenue for Dec 31, 2023 was $52.35 million, a 17.61% increase from 2022.
  • Apyx Medical's annual revenue for 2022 was $44.51 million, a 8.26% decrease from 2021.
  • Apyx Medical's annual revenue for 2021 was $48.52 million, a 75.08% increase from 2020.
  • Apyx Medical's annual revenue for 2020 was $27.71 million, a 1.86% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.